Dr. Clara Man-Ching Olcott, MD

Dr. Olcott practices at Foothill Ambulatory Surgery Center in Upland, California.

Dr. Olcott's NPI, 1215291612, was assigned on June 29, 2012. Dr. Olcott graduated from The University of New Mexico School of Medicine in 2012. Dr. Olcott holds California license A156211.

Dr. Olcott's primary practice is Foothill Ambulatory Surgery Center, at 1030 East Foothill Blvd #101b, Upland, CA 91786. The practice phone is (909) 981-5859.

Dr. Olcott's primary practice is Foothill Ambulatory Surgery Center in Upland, California. Dr. Olcott is also affiliated with San Antonio Regional Hospital. The medical group on file is Inland Ear, Nose and Throat and Facial Plastics. Dmand AI also links Dr. Olcott to 2 more hospitals and 1 medical group, each named with a free account. Dr. Olcott's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Olcott practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Olcott's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Olcott is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Olcott's licenses on file in 3 states: California, New York and Virginia.

Dmand AI lists chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment, larynx and vocal cord disease and swimmer's ear among the conditions Dr. Olcott treats.

CMS data shows 1,411 Medicare services from Dr. Olcott across 9 procedure codes in 2024, for 583 Medicare patients. Medicare paid $120,139 for them. Every service was in an office.

CMS counts 583 Medicare patients who saw Dr. Olcott in 2024. The largest group is 65 to 74, with 251 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Olcott's median patient age at 61, with 55% women.

In 2024, Dr. Olcott wrote 1,275 Medicare Part D claims for 489 patients. 96% of them were for generic drugs. CMS names the drug for 1,181 of them, across 21 drugs with 11 or more claims each, at $20,728 in total drug cost. In 2023, CMS named 842 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Olcott for performance year 2024, reported individually. Dr. Olcott accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Olcott, published from 2013 to 2018. 2013 was the busiest year, with 2. The most frequent topics are Cholesterol and Diagnosis, Differential. Dr. Olcott has published most often in Am J Otolaryngol. Dr. Olcott's most frequent co-authors are Christine Blanche Franzese, MD, Katherine Ruth Gentry, MD and Daniel W. Karakla, MD.

CMS Open Payments shows 238 general payments to Dr. Olcott from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 85% of the total. Intersect ENT, Inc. paid the most, $1,813.

Dmand AI lists 4 awards for Dr. Olcott, most recently Humanitarian Travel Grant in 2017. Dr. Olcott serves on AAO-HNS Women in Otolaryngology.

Dr. Olcott graduated from The University of New Mexico School of Medicine in 2012.

Dr. Olcott is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.